This post was originally published on Sherwood News.
Earlier this month, Novo predicted that its sales would decline by between 5% and 13% in 2026 amid rising competition.
Novo Nordisk sinks after its experimental obesity drug falls short of Eli Lilly’s in head-to-head trial
Leave a Reply